Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is a complex task, with constantly evolving case law and practice on both sides of the Atlantic. In this webinar, AWA’s experts focus on how to create, defend and litigate these patents in Europe and elsewhere.
Patenting Antibody and Cell Therapies – What to Do and What Not to Do
You may also be interested in:
Denmark takes a stand against deepfakes – rules are not yet law
Denmark has received international attention for its political agreement aimed at protecting individuals from misuse of their likeness and
Paris Court rules Hermès’ copyright and trademark infringed in upcycled fashion case
On April 10, 2025, the Paris Judicial Court handed down a pivotal decision in favour of Hermès, finding that
Chinese courts see upsurge in criminal IP litigation
On 21 April 2025 the Supreme People’s Court released an annual report entitled “The Status of Judicial Protection of